National Laboratory for Meningitis and Pneumococcal Infections, Laboratory for Meningitis, Pneumonia and Pneumococcal Infection, Center of Bacteriology, Brazil.
National Laboratory for Meningitis and Pneumococcal Infections, Laboratory for Meningitis, Pneumonia and Pneumococcal Infection, Center of Bacteriology, Brazil.
Vaccine. 2019 Aug 23;37(36):5357-5363. doi: 10.1016/j.vaccine.2019.07.043. Epub 2019 Jul 24.
Brazil introduced the 10-valent pneumococcal vaccine (PCV10) to the routine national immunization program (NIP) in March 2010. In 2017, we investigated the effects of PCV10 on nasopharyngeal carriage of vaccine-types (VT) and non-vaccine-types (NVT) of Streptococcus pneumoniae (Spn) among children living in São Paulo city. We also compared the prevalence of VT and NVT with previous carriage surveys performed in 2010 (baseline) and 2013.
The carriage survey was conducted among 531 children, aged 12 months to <24 months, recruited from public Primary Health Units during the immunization campaign, using previous surveys methodology, except for qPCR, which was performed in the 2017 survey only.
No statistical difference was found in the prevalence of Spn either by culture (59.7%) or by qPCR (61.2%). Spn carriage increased from 40.3% (baseline) to 59.7% (2017 survey) (p < 0.001). Colonization by VT isolates significantly decreased by 90.9% (19.8-1.8%) and 95.5% (19.8-0.9%) in the 2013 and 2017 surveys, respectively, compared to that at baseline. NVT isolates increased significantly by 128% (19.6-44.8%) and 185% (19.6-55.9%) in the respective post-PCV10 surveys, most led to high prevalence of serotypes 6C (27%), 15B (9.8%), 19A (9.2%), 15A (6.0%), and 16F (5.7%). In 2017, reduction in serotype 6A (4.2-0.6%, p < 0.001) and increase in serotype 19A (1.8-6.0%, p = 0.001) were found; serotype 3 isolate was not detected in the present survey. We identified the emergence of 19A isolates CC320, associated with high penicillin (MIC ≥ 2.0 mg/L) and cefotaxime (MIC ≥ 1.0 mg/L) values.
After 7 years of PCV10 introduction in the NIP, colonization by VT among toddlers decreased substantially to a residual level, along with substantial serotype replacement by novel serotypes not present in any current conjugated pneumococcal vaccine and serotype 19A. The present findings can assist policy decisions in Brazil.
巴西于 2010 年 3 月将 10 价肺炎球菌结合疫苗(PCV10)纳入常规国家免疫计划(NIP)。2017 年,我们调查了 PCV10 对圣保罗市儿童鼻咽携带疫苗型(VT)和非疫苗型(NVT)肺炎链球菌(Spn)的影响。我们还比较了与 2010 年(基线)和 2013 年进行的先前带菌调查相比,VT 和 NVT 的流行率。
使用以前的调查方法,对来自公共初级保健单位的 531 名 12 个月至<24 个月龄的儿童进行了带菌调查,除 qPCR 外,2017 年的调查仅进行 qPCR。
培养法(59.7%)和 qPCR 法(61.2%)检测到的 Spn 携带率均无统计学差异。Spn 携带率从 40.3%(基线)增加到 59.7%(2017 年调查)(p<0.001)。与基线相比,VT 分离株的定植分别显著下降了 90.9%(19.8-1.8%)和 95.5%(19.8-0.9%)。NVT 分离株在接种 PCV10 后的调查中分别显著增加了 128%(19.6-44.8%)和 185%(19.6-55.9%),其中血清型 6C(27%)、15B(9.8%)、19A(9.2%)、15A(6.0%)和 16F(5.7%)的流行率最高。2017 年发现血清型 6A 减少(4.2-0.6%,p<0.001)和血清型 19A 增加(1.8-6.0%,p=0.001);目前的调查未检测到血清型 3 分离株。我们发现了与高青霉素(MIC≥2.0mg/L)和头孢噻肟(MIC≥1.0mg/L)值相关的 CC320 型 19A 分离株的出现。
在 NIP 中引入 PCV10 7 年后,幼儿的 VT 定植显著减少到残留水平,同时新型血清型替代了目前任何结合肺炎球菌疫苗中都不存在的新型血清型,以及血清型 19A。本研究结果可以为巴西的政策决策提供参考。